查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1923638

個人劑量監測服務市場按設備類型、部署類型、應用和最終用戶行業分類 - 全球預測 2026-2032 年

Personal Dose Monitoring Service Market by Device Type, Deployment Mode, Application, End User Industry - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，個人劑量監測服務市場價值將達到 4.693 億美元，到 2026 年將成長至 5.0883 億美元，到 2032 年將達到 8.6102 億美元，複合年成長率為 9.05%。

關鍵市場統計數據
基準年 2025 4.693億美元
預計年份：2026年 5.0883億美元
預測年份 2032 8.6102億美元
複合年成長率 (%) 9.05%

個人化暴露追蹤如何透過持續測量、整合分析和人性化的實施策略重新定義安全措施和臨床實踐

個人劑量監測已成為職業安全、臨床照護和環境管理交叉領域的關鍵職能。過去十年，技術創新和監管力度的加強顯著改變了各機構測量、報告和應對暴露數據的方式。現代系統結合了微型感測器、安全的資料架構和分析功能，能夠將原始資料轉化為可供現場工作人員和臨床團隊使用的實用資訊。

識別技術、監管和人性化的趨勢的融合點，這些趨勢將重塑劑量監測解決方案的策略方向和應用路徑。

個人劑量監測領域正經歷一系列變革，這些變革是由技術、監管和勞動力趨勢的整合所驅動的。首先，感測器性能的提升和低功耗無線連接的廣泛應用，使得設備運作更長時間，從而促進其在移動性和隱蔽性至關重要的環境中得到應用。其次，基於雲端的分析和邊緣運算技術的進步，為監管人員和臨床醫生提供了近乎即時的風險資訊，從而能夠更快地進行干預，並縮短從發現到響應的延遲時間。

了解2025年美國關稅調整對劑量監測技術部署的採購、供應鏈韌性與籌資策略的影響

2025年美國生效的關稅調整和貿易政策變更將進一步增加個人劑量監測相關技術的採購和供應鏈規劃的複雜性。相關人員報告稱，關稅稅目變更和分類更新加重了跨境運輸的行政負擔，迫使採購團隊重新評估供應商合約和總到岸成本假設。為此，製造商和經銷商正在評估替代籌資策略，轉移部分生產流程，並更新物流工作流程，以降低關稅風險並確保供應連續性。

一種基於細分的詳細觀點，將設備類別、特定產業要求、部署模式和應用環境與實施和管治選擇相匹配。

深入的細分對於根據個人劑量監測的不同應用場景自訂功能至關重要。基於設備類型，該生態系統涵蓋了基於雲端的分析平台（用於聚合和關聯暴露數據）、固定監測系統（用於提供基準值）、行動應用程式（允許現場負責人存取警報和歷史記錄）以及穿戴式設備（為一線工作人員提供個人化、連續的讀數）。每類設備在測量精度、覆蓋範圍和用戶操作便利性之間各有優劣，而滿足操作需求的最佳配置通常需要結合多種設備類型。

美洲、歐洲、中東和非洲以及亞太地區的採用趨勢和策略考量對採購、整合和商業化的影響

區域趨勢影響個人劑量監測技術的應用、監管要求和夥伴關係模式。在美洲，成熟的法規結構、醫療服務提供者的集中以及對職業安全的高度重視，推動了綜合監測方案的早期應用。在採購方面，傾向於選擇能夠與現有電子健康記錄和職業健康系統互通性的解決方案。該地區的跨境貿易以及與大型製造地的接近性也影響供應商的選擇和物流規劃。

如何透過感測器創新、整合分析、監管能力和服務主導的市場推廣模式來建立競爭優勢

個人劑量監測領域的主要企業正從多個維度進行差異化競爭，包括感測器精度、資料架構、法規遵循支援以及涵蓋安裝、校準和持續分析的端到端服務。一些供應商專注於硬體創新，致力於縮小尺寸和延長電池續航時間，以實現隱藏、長期佩戴。另一些供應商則專注於平台功能，提供基於角色的儀錶板、自動化報告和基於雲端的分析功能，並配備API介面，以便輕鬆整合到職業健康管理系統和臨床資訊系統中。

實際的實施和管治步驟，幫助領導者將監測試點項目轉化為可擴展的項目，從而提升安全性、營運效率和臨床品質。

產業領導者應採取策略性的分階段方法，以最大限度地發揮個人劑量監測技術的價值。首先，明確定義與臨床或營運目標相符的應用情境和成功指標，確保所選設備和分析方法與這些目標直接相關。試點計畫應進行範圍界定，以檢驗與現有IT系統的整合，並評估使用者在正常運作條件下的接受度。在試點階段密切關注人為因素，將有助於減少規模化推廣時的阻力。

結合相關人員訪談、標準審查和情境分析的混合方法、證據驅動型方法，為實施者提供可操作且檢驗的見解。

本分析的調查方法整合了第一手和第二手研究證據，旨在對趨勢和影響進行平衡且可重複的評估。第一手資料包括對來自國防、醫療保健、核能以及石油和天然氣行業的技術高管、採購負責人和合規專業人員進行的結構化訪談。這些訪談旨在了解組織在實施監測專案時面臨的實際應用經驗、採購考量和營運權衡。

概述綜合監測專案如何從合規工具轉變為安全、臨床洞察和環境管理的策略驅動力

總之，個人劑量監測正處於一個轉折點，技術成熟度、不斷演進的法規以及相關人員的期望匯聚在一起，共同推動更積極主動的暴露管理。當設備、分析和管治三者融合，能夠提供精準的測量結果、及時的警報以及與臨床和營運工作流程的無縫整合時，其最具吸引力的價值提案便會顯現。那些將監測定位為一項程序化能力，並輔以清晰的指標、強力的管治和迭代式變更管理的機構，將從中獲得最大的利益。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依設備類型分類的個人劑量監測服務市場

  • 基於雲端的分析
  • 固定監控系統
  • 行動應用
  • 穿戴式裝置

9. 依部署模式分類的個人劑量監測服務市場

  • 基於雲端的
  • 本地部署

第10章：按應用分類的個人劑量監測服務市場

  • 環境監測
    • 空氣品質
    • 水污染
  • 病患監測
    • 癌症治療監測
    • 診斷放射學
  • 研究與開發
    • 學術研究
    • 臨床試驗
  • 工人安全
    • 工業檢驗
    • 放射科

第11章：以最終用戶產業分類的個人劑量監測服務市場

  • 防禦
    • 邊防安全
    • 軍事設施
  • 衛生保健
    • 診斷影像中心
    • 醫院
  • 核能發電
    • 發電廠
    • 研究所
  • 石油和天然氣
    • 探勘現場
    • 煉油廠

12. 各地區個人劑量監測服務市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 個人劑量監測服務市場（依群體分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國個人劑量監測服務市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國個人劑量監測服務市場

第16章：中國個人劑量監測服務市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Atomtex SPE
  • Berthold Technologies GmbH & Co. KG
  • Canberra Industries, Inc.
  • Fluke Biomedical
  • Fuji Electric Co., Ltd.
  • Global Dosimetry Solutions, Inc.
  • IBA Dosimetry GmbH
  • Landauer, Inc.
  • Ludlum Measurements, Inc.
  • Mirion Technologies, Inc.
  • Nuvia Dynamics
  • Panasonic Holdings Corporation
  • Polimaster, Inc.
  • Prosys, Inc.
  • Radiation Detection Company, Inc.
  • RadPro International GmbH
  • SE International, Inc.
  • Thermo Fisher Scientific Inc.
  • TSI Incorporated
  • Unfors Raysafe AB
Product Code: MRR-867BED9AA0B6

The Personal Dose Monitoring Service Market was valued at USD 469.30 million in 2025 and is projected to grow to USD 508.83 million in 2026, with a CAGR of 9.05%, reaching USD 861.02 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 469.30 million
Estimated Year [2026] USD 508.83 million
Forecast Year [2032] USD 861.02 million
CAGR (%) 9.05%

How personalized exposure tracking is redefining safety and clinical practice through continuous measurement, integrated analytics, and human-centered deployment strategies

Personal dose monitoring has emerged as a critical capability at the intersection of occupational safety, clinical care, and environmental stewardship. Over the last decade, technological innovation and heightened regulatory scrutiny have transformed how organizations measure, report, and act on exposure data. Contemporary systems combine miniaturized sensors, secure data architectures, and analytics that translate raw readings into actionable insights for frontline workers and clinical teams alike.

The move from episodic sampling to continuous, individualized monitoring reflects a broader shift toward preventive risk management. In healthcare settings, for example, the ability to track cumulative exposure for patients undergoing multiple imaging procedures enhances treatment planning and supports informed consent. In industrial environments, wearable devices and mobile applications provide real-time alerts that reduce acute incidents and support long-term occupational health strategies. Consequently, investment decisions now weigh integration potential as heavily as sensor performance, with interoperability and user experience becoming decisive factors.

As this introduction underscores, the value of personal dose monitoring lies not only in measurement accuracy but in the system's capacity to connect people, processes, and data. Organizations that align technology selection with clear operational objectives and governance frameworks are best positioned to move beyond compliance and achieve measurable improvements in safety, cost control, and stakeholder trust.

Identifying converging technological, regulatory, and human-centered trends that are reshaping the strategic direction and adoption pathways for dose monitoring solutions

The landscape for personal dose monitoring is undergoing a series of transformative shifts driven by converging technological, regulatory, and workforce trends. First, sensor performance improvements and the proliferation of low-power wireless connectivity have enabled devices to operate for longer durations with minimal user burden, fostering adoption in settings where mobility and unobtrusiveness are essential. Second, advances in cloud-based analytics and edge processing bring near-real-time risk intelligence to supervisors and clinicians, enabling faster interventions and reducing latency between detection and response.

Regulatory frameworks are evolving to reflect these technological capabilities. Agencies are clarifying expectations around data provenance, calibration, and reporting, which raises the bar for vendor compliance while creating opportunities for products that emphasize traceability and auditability. At the same time, organizational priorities are shifting from episodic compliance checks to continuous exposure management programs that combine monitoring, training, and process redesign.

Finally, the human factor is central to these shifts. Systems that prioritize user experience, privacy-preserving data handling, and clear communication of risk are gaining traction. As a result, vendors and adopters are rethinking deployment strategies to foreground worker acceptance, clinical workflow compatibility, and change management. Taken together, these dynamics are steering the market toward integrated solutions that deliver measurable operational and clinical benefits rather than stand-alone sensing hardware.

Understanding how the 2025 United States tariff adjustments are reshaping procurement, supply-chain resilience, and sourcing strategies for dose monitoring technology deployments

Tariff changes and trade policy adjustments in the United States for 2025 have introduced additional complexity into procurement and supply-chain planning for technologies tied to personal dose monitoring. Stakeholders report that altered tariff lines and classification updates have increased the administrative burden for cross-border shipments, prompting procurement teams to revisit vendor contracts and total landed cost assumptions. In response, manufacturers and distributors are evaluating alternative sourcing strategies, relocating certain manufacturing steps, and updating logistics workflows to mitigate tariff exposure and ensure continuity of supply.

These adjustments also influence product design choices, as some vendors reassess the geographic footprint of component sourcing to preserve cost competitiveness. Meanwhile, procurement cycles are lengthening where decision-makers seek greater clarity on duty liabilities and customs compliance before finalizing large-scale deployments. For smaller adopters and those with limited procurement capacity, the unpredictability introduced by tariff shifts can delay pilots and reduce the scope of initial rollouts.

Regulatory coordination between customs authorities and standard-setting bodies is emerging as a critical enabler for smoother trade flows. Organizations with proactive trade-compliance capabilities and flexible supplier relationships are in a better position to manage near-term volatility. Strategically, the combined effect of these tariff-related dynamics is to elevate the importance of supply-chain resilience, local partnership networks, and contract terms that explicitly address cross-border duties and regulatory changes.

Detailed segmentation-driven perspectives that align device classes, industry-specific requirements, deployment modes, and application contexts to implementation and governance choices

Insightful segmentation is essential to match capabilities to the diverse use cases for personal dose monitoring. Based on device type, the ecosystem spans cloud-based analytics platforms that aggregate and contextualize exposure data, fixed monitoring systems that provide area-based baselines, mobile applications that enable field personnel to access alerts and historical records, and wearable devices that deliver individualized, continuous readings for frontline workers. Each device class brings trade-offs between granularity, coverage, and user burden, and the optimal configuration often combines multiple device types to meet operational needs.

Based on end user industry, adoption patterns and procurement drivers vary significantly across defense, healthcare, nuclear power, and oil and gas. Within defense, the primary focus areas include border security and military installations where durability, cybersecurity, and chain-of-custody for exposure data are paramount. Healthcare settings prioritize diagnostic imaging centers and hospitals, where patient monitoring for cumulative exposure during cancer therapy monitoring and diagnostic radiology is a key use case. Nuclear power stakeholders include power plants and research institutions that require rigorous calibration standards and integrated environmental monitoring. Oil and gas operators deploy monitoring across exploration sites and refineries, emphasizing worker safety under challenging environmental conditions.

Based on deployment mode, organizations evaluate cloud-based solutions for their scalability and remote management benefits versus on-premise deployments that offer tighter control over sensitive data and localized analytics. Based on application, the domain of use extends to environmental monitoring, patient monitoring, research and development, and worker safety. Environmental monitoring splits into air quality and water contamination applications that inform broader public health initiatives, while patient monitoring encompasses cancer therapy monitoring and diagnostic radiology needs that tie directly to clinical decision pathways. Research and development users span academic research and clinical trials, each demanding rigorous data integrity and reproducibility standards. Worker safety applications focus on industrial inspection and radiology workflows where real-time alerts, incident logging, and post-exposure follow-up are operational priorities.

Taken together, these segmentation lenses reveal that solution design, procurement strategy, and post-deployment governance must be tailored not only to technical requirements but to the organizational culture, regulatory constraints, and use-case-specific workflows that drive adoption and value realization.

Regional adoption dynamics and strategic considerations across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence procurement, integration, and commercialization

Regional dynamics shape technology adoption, regulatory expectations, and partnership models for personal dose monitoring. In the Americas, mature regulatory frameworks, a concentration of healthcare providers, and a strong emphasis on occupational safety support early adoption of integrated monitoring programs; procurement often favors solutions that demonstrate interoperability with existing electronic health records and occupational health systems. Cross-border trade within the region and proximity to large manufacturing bases also influence supplier selection and logistics planning.

In Europe, Middle East & Africa, heterogeneous regulatory environments and diverse healthcare infrastructures mean that deployments must be highly adaptable. Western European markets tend to prioritize data protection, device certification, and integration with national health systems, whereas markets in other parts of the region may focus on ruggedized devices and cost-effective deployment models suitable for resource-constrained settings. Partnerships with regional integrators and local service providers are often decisive in these geographies.

Asia-Pacific displays a wide spectrum of adoption stages, from highly digitized healthcare ecosystems to rapidly industrializing markets requiring scalable, low-cost solutions. The region's manufacturing capacity and supply-chain agility support rapid prototyping and localized production, which can reduce lead times and enhance customization. Across all regions, interoperability, compliance with local standards, and culturally informed user engagement strategies are critical to accelerating adoption and ensuring sustainable program outcomes.

How competitive differentiation is being crafted through sensor innovation, integrated analytics, regulatory competence, and service-driven go-to-market models

Leading companies in the personal dose monitoring space are differentiating along several dimensions: sensor fidelity, data architecture, regulatory compliance support, and end-to-end services that include installation, calibration, and ongoing analytics. Some vendors concentrate on hardware innovation, advancing miniaturization and battery life to enable unobtrusive long-term wear. Others emphasize platform capabilities, offering cloud-based analytics with role-based dashboards, automated reporting, and APIs that facilitate integration with occupational health and clinical information systems.

Collaborative partnerships between device manufacturers, software providers, and systems integrators are becoming more common as customers demand turnkey solutions that span procurement, deployment, and maintenance. Value-added services such as training, accreditation support, and longitudinal exposure analysis are increasingly part of vendor propositions. Companies that can demonstrate rigorous quality management systems, clear calibration and traceability processes, and strong post-sales support tend to secure larger institutional contracts because they reduce implementation risk and support compliance.

Competitive positioning is also shaped by go-to-market models: some firms prioritize direct sales to large healthcare systems and industrial operators, while others leverage distribution networks and channel partners to reach smaller customers and geographically dispersed sites. Ultimately, leading organizations balance product innovation with service excellence and regulatory competence to meet the diverse needs of clinical, defense, nuclear, and industrial customers.

Actionable deployment and governance steps for leaders to convert monitoring pilots into scalable programs that deliver safety, operational efficiency, and clinical quality

Industry leaders should take a strategic, phased approach to capture the most value from personal dose monitoring technologies. First, start with a clear articulation of use cases and success metrics that align with clinical or operational objectives, ensuring the selection of devices and analytics that map directly to those outcomes. Pilots should be scoped to validate integration with existing IT systems and to assess user acceptance under normal operating conditions; careful attention to human factors during pilots reduces friction during scale-up.

Second, prioritize interoperability and data governance. Select solutions that offer standardized interfaces and strong data provenance capabilities to simplify integration with electronic health records, occupational health platforms, and incident management systems. Robust governance frameworks that define data ownership, retention, and access controls will protect sensitive exposure data and support regulatory compliance.

Third, invest in supply-chain resilience and contractual safeguards. Given the changing trade and tariff environment, contracts should explicitly address duties, warranties, service-level expectations, and parts availability. Build relationships with regional partners to shorten lead times and provide local support. Finally, create a change management plan that includes training, communication of value to frontline users, and mechanisms for feedback-driven iteration. By combining rigorous technical evaluation with attention to organizational adoption, leaders can transform monitoring from a compliance obligation into a strategic capability that improves safety, operational efficiency, and clinical quality.

A mixed-methods, evidence-driven approach combining stakeholder interviews, standards review, and scenario analysis to produce actionable and verifiable insights for implementers

The research methodology underpinning this analysis combines primary and secondary evidence to produce a balanced, reproducible assessment of trends and implications. Primary inputs include structured interviews with technical leaders, procurement officers, clinical users, and compliance specialists across defense, healthcare, nuclear, and oil and gas sectors. These interviews were designed to capture real-world deployment experiences, procurement considerations, and the operational trade-offs organizations encounter when implementing monitoring programs.

Secondary inputs consist of a systematic review of technical standards, regulatory guidance, product literature, and peer-reviewed studies related to sensor performance, data integrity, and exposure management practices. The methodology emphasizes triangulation, cross-referencing statements from interviews with documented standards and published technical evaluations to validate claims about performance, interoperability, and use-case fit. Where appropriate, scenario analysis was used to explore the implications of supply-chain disruptions and regulatory changes on procurement timelines and deployment risk.

Quality assurance measures include validation of technical claims against calibration and certification documentation, and peer review of findings by domain experts. The approach intentionally focuses on practical adoption barriers and enablers rather than hypothetical market sizing, ensuring the analysis is actionable for practitioners planning pilots, procurement, and scale-up.

Concluding synthesis on how integrated monitoring programs can transition from compliance tools to strategic enablers of safety, clinical insight, and environmental stewardship

In conclusion, personal dose monitoring stands at an inflection point where technological maturity, regulatory evolution, and stakeholder expectations are converging to enable more proactive exposure management. The most compelling value propositions arise when devices, analytics, and governance converge to deliver accurate readings, timely alerts, and seamless integration with clinical and occupational workflows. Organizations that treat monitoring as a programmatic capability-supported by clear metrics, robust governance, and iterative change management-will realize the greatest benefits.

Near-term success will depend on pragmatic decisions: selecting device mixes that balance granularity with usability, choosing deployment modes that respect data sensitivity, and building supplier relationships that mitigate supply-chain uncertainty. For public and private entities alike, the ability to demonstrate traceability, data integrity, and user-centered design will be central to achieving stakeholder buy-in. As adoption grows, the focus should shift from isolated implementations to longitudinal exposure management strategies that inform training, preventive maintenance, and clinical decision-making.

Ultimately, the path forward favors integrative thinking: aligning technology choices with organizational goals, regulatory requirements, and the human realities of frontline users. When executed thoughtfully, personal dose monitoring can move from a compliance instrument to a strategic enabler of safer workplaces, more informed clinical care, and improved environmental stewardship.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Personal Dose Monitoring Service Market, by Device Type

  • 8.1. Cloud-Based Analytics
  • 8.2. Fixed Monitoring Systems
  • 8.3. Mobile Applications
  • 8.4. Wearable Devices

9. Personal Dose Monitoring Service Market, by Deployment Mode

  • 9.1. Cloud-Based
  • 9.2. On-Premise

10. Personal Dose Monitoring Service Market, by Application

  • 10.1. Environmental Monitoring
    • 10.1.1. Air Quality
    • 10.1.2. Water Contamination
  • 10.2. Patient Monitoring
    • 10.2.1. Cancer Therapy Monitoring
    • 10.2.2. Diagnostic Radiology
  • 10.3. Research And Development
    • 10.3.1. Academic Research
    • 10.3.2. Clinical Trials
  • 10.4. Worker Safety
    • 10.4.1. Industrial Inspection
    • 10.4.2. Radiology

11. Personal Dose Monitoring Service Market, by End User Industry

  • 11.1. Defense
    • 11.1.1. Border Security
    • 11.1.2. Military Installations
  • 11.2. Healthcare
    • 11.2.1. Diagnostic Imaging Centers
    • 11.2.2. Hospitals
  • 11.3. Nuclear Power
    • 11.3.1. Power Plants
    • 11.3.2. Research Institutions
  • 11.4. Oil And Gas
    • 11.4.1. Exploration Sites
    • 11.4.2. Refineries

12. Personal Dose Monitoring Service Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Personal Dose Monitoring Service Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Personal Dose Monitoring Service Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Personal Dose Monitoring Service Market

16. China Personal Dose Monitoring Service Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Atomtex SPE
  • 17.6. Berthold Technologies GmbH & Co. KG
  • 17.7. Canberra Industries, Inc.
  • 17.8. Fluke Biomedical
  • 17.9. Fuji Electric Co., Ltd.
  • 17.10. Global Dosimetry Solutions, Inc.
  • 17.11. IBA Dosimetry GmbH
  • 17.12. Landauer, Inc.
  • 17.13. Ludlum Measurements, Inc.
  • 17.14. Mirion Technologies, Inc.
  • 17.15. Nuvia Dynamics
  • 17.16. Panasonic Holdings Corporation
  • 17.17. Polimaster, Inc.
  • 17.18. Prosys, Inc.
  • 17.19. Radiation Detection Company, Inc.
  • 17.20. RadPro International GmbH
  • 17.21. S.E. International, Inc.
  • 17.22. Thermo Fisher Scientific Inc.
  • 17.23. TSI Incorporated
  • 17.24. Unfors Raysafe AB

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PERSONAL DOSE MONITORING SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLOUD-BASED ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLOUD-BASED ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLOUD-BASED ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY FIXED MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY FIXED MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY FIXED MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY MOBILE APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY MOBILE APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY MOBILE APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WEARABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WEARABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLOUD-BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLOUD-BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLOUD-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ON-PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ON-PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY AIR QUALITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY AIR QUALITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY AIR QUALITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WATER CONTAMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WATER CONTAMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WATER CONTAMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CANCER THERAPY MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CANCER THERAPY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CANCER THERAPY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DIAGNOSTIC RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ACADEMIC RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY INDUSTRIAL INSPECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY INDUSTRIAL INSPECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY INDUSTRIAL INSPECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RADIOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RADIOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RADIOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY BORDER SECURITY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY BORDER SECURITY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY BORDER SECURITY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY MILITARY INSTALLATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY MILITARY INSTALLATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY MILITARY INSTALLATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY POWER PLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY POWER PLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY POWER PLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY EXPLORATION SITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY EXPLORATION SITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY EXPLORATION SITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY REFINERIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY REFINERIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY REFINERIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 223. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 226. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 227. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 228. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 229. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 230. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 231. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 232. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 233. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 234. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 235. GCC PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 262. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 265. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 267. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 268. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 269. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 270. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 271. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 272. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 273. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 274. G7 PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 275. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 276. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 277. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 278. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY ENVIRONMENTAL MONITORING, 2018-2032 (USD MILLION)
  • TABLE 280. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY PATIENT MONITORING, 2018-2032 (USD MILLION)
  • TABLE 281. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 282. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY WORKER SAFETY, 2018-2032 (USD MILLION)
  • TABLE 283. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY END USER INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 284. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEFENSE, 2018-2032 (USD MILLION)
  • TABLE 285. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY HEALTHCARE, 2018-2032 (USD MILLION)
  • TABLE 286. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY NUCLEAR POWER, 2018-2032 (USD MILLION)
  • TABLE 287. NATO PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY OIL AND GAS, 2018-2032 (USD MILLION)
  • TABLE 288. GLOBAL PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES PERSONAL DOSE MONITORING SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES PERSONAL DOSE MONITORING SERVICE MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032